Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.
about
The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejectionEffects of complement activation on allograft injuryMHC class I signaling: new functional perspectives for an old moleculeMonocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.Antibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisThe Complement System and Antibody-Mediated Transplant RejectionMolecules Great and Small: The Complement System.Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation.Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation.Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+ NIK+ signalosome on Rab5+ endosomes.An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLAAntibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft InjuryAntibody-mediated graft injury: complement-dependent and complement-independent mechanisms.Graft microvascular disease in solid organ transplantation.Complement as a multifaceted modulator of kidney transplant injury.Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.Innate immune mechanisms in transplant allograft vasculopathy.Recent advances in allograft vasculopathy.Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Complement in Kidney TransplantationHLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion.Complement in Non-Antibody-Mediated Kidney Diseases.Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy.Complement C5 Inhibition Reduces T Cell-Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice.Aged B cells alter immune regulation of allografts in mice.Does prolonged post-mortem cold ischemic harvesting time influence cryopreserved pulmonary homograft tissue integrity?Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys.Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin.HLA Class I and Class II-Induced Intracellular Signaling and Molecular Associations in Primary Human Endothelial Cells.The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice.Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.Utility of protocol kidney biopsies for de novo donor-specific antibodies.Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin.Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.
P2860
Q26862195-A1D076F6-676E-421C-A594-8FA8508D8D3AQ26995453-AF544933-8C47-41E3-91CB-59B915ED86C6Q27000194-E0BF1E55-6215-477A-A37E-EA1BC2967206Q27314948-EA1DB1FB-DF03-4DB5-8F34-31FF75EF59F1Q28076193-53FB7C09-4162-4D52-9FF8-D47F6DA3C504Q28084366-DB681068-C9C4-4E2B-A1C6-C3A30BD846E5Q28087773-624C18AA-C8F2-4646-A4D2-487FF58DDDB8Q33419651-177FCDA0-3979-412A-8B6C-E0289B6F6148Q33829159-933BE949-B1BD-48D4-AD5E-2C6D85C210CAQ34901573-C5A2604E-3E79-432E-BAE0-61881DA6DF82Q35874401-D872A815-228C-4ED7-80F0-CA92A2767841Q35946248-2C6C8962-1235-48DC-9E10-48F62C4C9976Q36302476-15C2E28A-D8E6-46BD-912F-472CAAF5FC13Q37720377-C10E7F90-2333-4817-A9B8-3958033C5355Q38169496-D424E818-F9A8-4973-BDFF-B9F12F4A3BFFQ38216381-A4762B9C-1C3D-42AC-8270-DD9C4A5E8931Q38217273-F224AE06-4ADF-469D-9B4E-AFCAE67F90E3Q38218005-49A304DC-C350-448F-8132-1020557718F1Q38808100-D6B7C1AB-9E14-4950-ADA3-62C213D57BE5Q39023584-1526CE9F-5C3A-42F4-B8F6-B9D8B6881FD7Q39097599-23164BC2-5E23-4F78-9275-21C4F21684F9Q39217968-EEAF03EF-2C21-4722-AB9D-A097B7EAE726Q39366396-EBE9478F-3959-49A6-917D-54C49E24DD98Q39371134-DB90A46A-646B-4829-9D87-A8D24190BC57Q40266578-037821AE-8610-47B4-BC12-9DF2C57A35CCQ40986583-FE4E63B9-B125-4794-9942-B33D3A7285B2Q41068034-F5CBBDB8-128A-478D-8446-FC13CCAF2353Q41631576-9D83A914-9BC7-4DF0-9BA8-002016765F74Q43154528-04F123D4-9A98-4AF8-92D2-C2E9284DC708Q46558612-EF981E3A-6979-47A9-8508-EC81AD76D97CQ47175243-D550CEC9-32E7-477C-B657-1C703845F4A6Q47204087-6CF568D2-E33C-406B-96F5-6E43A10AADF4Q47673511-6966FB41-B8DC-46C1-A1E3-7D145FFCE8F2Q49521510-0EB11F60-E8E1-40AD-A37D-6D3C5FFE6272Q50042914-077760B9-0FC2-4960-BD0A-702DCE177DA8Q50504222-82B1BA45-CB19-4303-94BD-AFEE00A04315Q51121337-54A25983-B50F-4D73-B126-A28D00B3B6EEQ54967868-F56E37AD-A37C-44F8-A6AD-E8B5E55F6DA5
P2860
Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alloantibody and complement pr ...... ignaling in endothelial cells.
@en
Alloantibody and complement pr ...... ignaling in endothelial cells.
@nl
type
label
Alloantibody and complement pr ...... ignaling in endothelial cells.
@en
Alloantibody and complement pr ...... ignaling in endothelial cells.
@nl
prefLabel
Alloantibody and complement pr ...... ignaling in endothelial cells.
@en
Alloantibody and complement pr ...... ignaling in endothelial cells.
@nl
P2093
P2860
P1433
P1476
Alloantibody and complement pr ...... signaling in endothelial cells
@en
P2093
Dan Jane-Wit
George Tellides
Jordan S Pober
Julie Devalliere
Lingfeng Qin
Nancy C Kirkiles-Smith
Pamela Clark
Parwiz Abrahimi
Thomas D Manes
P2860
P304
P356
10.1161/CIRCULATIONAHA.113.002972
P407
P577
2013-09-17T00:00:00Z